Locally advanced basosquamous carcinoma: Our experience with sonidegib

Dermatol Ther. 2022 Jun;35(6):e15436. doi: 10.1111/dth.15436. Epub 2022 Mar 16.

Authors

Ludovica Toffoli¹, Marina Agozzino¹, Nicola di Meo¹, Iris Zalaudek¹, Claudio Conforti¹

Affiliation

¹ Dermatology Clinic of Trieste, Maggiore Hospital, University of Trieste, Trieste, Italy.

PMID: 35278014
DOI: 10.1111/dth.15436

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents* / therapeutic use
Biphenyl Compounds
Carcinoma, Basal Cell* / drug therapy
Carcinoma, Basosquamous* / drug therapy
Humans
Pyridines / adverse effects
Skin Neoplasms* / drug therapy

Substances

Antineoplastic Agents
Biphenyl Compounds
Pyridines
sonidegib